Browse All

Current Filters

CLEAR FILTER x

TITLE

Exploratory Analysis of PASADENA Open-label Extension Evaluating the Effect of Prasinezumab on the Progression of Motor Signs and Symptoms

Author:Pagano, Gennaro   Monnet, Annabelle   Reyes, Adriana   Simuni, Tanya   Postuma, Ronald   Pavese, Nicola   Stocchi, Fabrizio   Smigorski, Krzysztof   Gerbaldo, Valentina   Thomas, Riorge   Svoboda, Hanno   Fontoura, Paulo   Doody, Rachelle   Kerchner, Geoffrey   Brundin, Patrik   Bonni, Azad   Marek, Kenneth   Nikolcheva, Tania   

Session Name:S30: Movement Disorders: Clinical Trials in Movement Disorders  

Topic:Movement Disorders  

Program Number:S30.006  

Author Institution:Roche Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland  F. Hoffmann-La Roche Ltd, Basel, Switzerland  Northwestern University Feinberg School of Medicine, Chicago, IL  Montreal General Hospital, Montreal, QC, Canada  Newcastle University, Newcastle upon Tyne, England, United Kingdom  Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy  Excelya Germany GmbH, 78462, Germany  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Roche Diagnostics GmbH, DE, Basel, Switzerland  Invicro, A Konica Minolta Company, New Haven, CT  

Onset of Efficacy with Continuous, Subcutaneous Levodopa/carbidopa Infusion in Patients with Parkinson’s Disease Experiencing Motor Fluctuations

Author:Ellenbogen, Aaron   Stocchi, Fabrizio   Lopes, Nelson   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.012  

Author Institution:Michigan Institute for Neurological Disorders, Farmington Hills, MI  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  Neuroderm, Sermonde, Portugal